JSVSX
Price
$15.72
Change
-$0.15 (-0.95%)
Updated
Aug 15 closing price
Net Assets
84.47M
JVMSX
Price
$29.15
Change
-$0.22 (-0.75%)
Updated
Aug 15 closing price
Net Assets
23.59B
Interact to see
Advertisement

JSVSX vs JVMSX

Header iconJSVSX vs JVMSX Comparison
Open Charts JSVSX vs JVMSXBanner chart's image
Janus Henderson Small-Mid Cap Value S
Price$15.72
Change-$0.15 (-0.95%)
VolumeN/A
Net Assets84.47M
JHancock Disciplined Value Mid Cap R2
Price$29.15
Change-$0.22 (-0.75%)
VolumeN/A
Net Assets23.59B
JSVSX vs JVMSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JSVSX vs. JVMSX commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JSVSX is a StrongBuy and JVMSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMSX has more cash in the bank: 23.6B vs. JSVSX (84.5M). JVMSX pays higher dividends than JSVSX: JVMSX (0.41) vs JSVSX (0.29). JSVSX was incepted earlier than JVMSX: JSVSX (14 years) vs JVMSX (13 years). JSVSX (2.68) is less costly to investors than JVMSX (1.26). JSVSX is a more actively managed with annual turnover of: 63.00 vs. JVMSX (49.00). JVMSX has a lower initial minimum investment than JSVSX: JVMSX (0) vs JSVSX (2500). JVMSX annual gain was more profitable for investors over the last year : 0.34 vs. JSVSX (-4.07). JSVSX return over 5 years is better than : 50.97 vs. JVMSX (48.09).
JSVSXJVMSXJSVSX / JVMSX
Total Expense Ratio1.191.2595%
Annual Report Gross Expense Ratio2.681.26213%
Fund Existence14 years13 years-
Gain YTD1.5508.72818%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets84.5M23.6B0%
Annual Yield % from dividends0.290.4169%
Returns for 1 year-4.070.34-1,195%
Returns for 3 years20.4110.96186%
Returns for 5 years50.9748.09106%
Returns for 10 years31.2841.6075%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FBTCX23.150.20
+0.87%
Fidelity Advisor Biotechnology C
CCMMX9.600.02
+0.21%
Conestoga Mid Cap Investors
ANDVX10.61N/A
N/A
Virtus NFJ Dividend Value R6
PCAQX87.40-0.22
-0.25%
Principal Capital Appreciation R5
TAGFX11.35-0.06
-0.53%
Transamerica Mid Cap Growth R6